miR-105 inhibits prostate tumour growth by suppressing CDK6 levels

Area of Science:

• Molecular Biology
• Oncology
• Gene Regulation

Background:

• MicroRNAs (miRNAs) play a crucial role in regulating gene expression within tumors.
• Understanding miRNA expression in prostate cancer is vital for comprehending tumor growth and progression.
• The specific role of miR-105 in prostate cancer pathogenesis remains largely unexplored.

Purpose of the Study:

• To investigate the expression profile of miRNAs in prostate tumor cell lines.
• To determine the functional role of the novel miRNA, miR-105, in prostate cancer.
• To evaluate miR-105 as a potential therapeutic target or biomarker for prostate cancer.

Main Methods:

• Compared miRNA expression in PC3 and DU145 prostate tumor cell lines versus normal prostate epithelial cells.
• Overexpressed miR-105 in PC3 and DU145 cells to assess its impact on tumorigenic properties.
• Evaluated tumor cell proliferation, anchorage-independent growth, invasion in vitro, and tumor growth in vivo xenograft models.
• Identified CDK6 as a putative target of miR-105.

Main Results:

• miR-105 levels were significantly decreased in both prostate tumor cell lines compared to normal cells.
• Overexpression of miR-105 inhibited tumor cell proliferation, anchorage-independent growth, and invasion in vitro.
• miR-105 overexpression suppressed tumor growth in vivo xenograft models.
• CDK6 was identified as a likely target mediating miR-105's anti-proliferative effects.

Conclusions:

• miR-105 functions as a tumor suppressor in prostate cancer by inhibiting cell proliferation and invasion.
• miR-105 may serve as a novel therapeutic target for reducing prostate tumor growth.
• Decreased miR-105 levels could indicate aggressive tumor behavior, suggesting its potential as a biomarker.